OUR SERVICES

Our strategic screening process is
designed to identify the most promising pharmacological candidates for new drug development.

End-to-end strategic screening using artificial intelligence begins with a large pool of compounds, potentially consisting of thousands or even millions of molecules, and narrows it down to a prioritized list of candidate compounds. This process is based on a series of predefined criteria, including the compound's potential efficacy, safety, ease of production, originality, and commercial potential. These candidates are then tested in the laboratory to determine their pharmacological properties. Compounds that exhibit the desired characteristics undergo further testing and evaluation, with the ultimate goal of identifying one or a few candidates for drug development.